Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Determination of Effectiveness of SilverHawk Peripheral Plaque Excision (SilverHawk Device) for the Treatment of Infrainguinal Vessels/Lower Extremities

NCT00883246 is registered in ClinicalTrials.gov with Medtronic Endovascular as lead sponsor.

NCT NCT00883246
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00883246 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Determination of Effectiveness of SilverHawk Peripheral Plaque Excision (SilverHawk Device) for the Treatment of Infrainguinal Vessels/Lower Extremities
Lead sponsor
Medtronic Endovascular
Phase
Not applicable
Overall status
Completed
Start date
April 30, 2009
Completion date
June 30, 2012
Enrollment
800 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

claudication, critical limb ischemia, peripheral arterial disease